---
figid: PMC3303762__IJVM2012-569654.003
figtitle: Hyperglycemia-induced endothelial dysfunction and activation
organisms:
- Homo sapiens
organisms_ner:
- Homo sapiens
- Danio rerio
pmcid: PMC3303762
filename: IJVM2012-569654.003.jpg
figlink: /pmc/articles/PMC3303762/figure/fig3/
number: F3
caption: Hyperglycemia-induced endothelial dysfunction and activation. (a) Hyperglycemia
  induces metabolic dysfunction through mitochondrial production of superoxide, resulting
  in PARP activation and subsequent altered glycolytic flux to enhance diacylglycerol
  production (DAG), methylglyoxal production, and hexosamine and polyol pathway activity.
  (b) Hyperglycemia-induced oxidative stress is further enhanced by metabolic overproduction
  of DAG and decreases in NADH+/reduced glutathione (GSH), as well as stimulation
  of the RAGE receptor. Oxidative stress reduces protective mediators (NO bioavailability)
  and enhances inflammatory transcription factor (NF-κB) activation resulting in inflammatory
  gene expression and leukocyte recruitment.
papertitle: 'Hyperglycemia and Endothelial Dysfunction in Atherosclerosis: Lessons
  from Type 1 Diabetes.'
reftext: Steven Daniel Funk, et al. Int J Vasc Med. 2012;2012:569654.
year: '2012'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9777339
figid_alias: PMC3303762__F3
figtype: Figure
redirect_from: /figures/PMC3303762__F3
ndex: 9a42a93d-deb8-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3303762__IJVM2012-569654.003.html
  '@type': Dataset
  description: Hyperglycemia-induced endothelial dysfunction and activation. (a) Hyperglycemia
    induces metabolic dysfunction through mitochondrial production of superoxide,
    resulting in PARP activation and subsequent altered glycolytic flux to enhance
    diacylglycerol production (DAG), methylglyoxal production, and hexosamine and
    polyol pathway activity. (b) Hyperglycemia-induced oxidative stress is further
    enhanced by metabolic overproduction of DAG and decreases in NADH+/reduced glutathione
    (GSH), as well as stimulation of the RAGE receptor. Oxidative stress reduces protective
    mediators (NO bioavailability) and enhances inflammatory transcription factor
    (NF-κB) activation resulting in inflammatory gene expression and leukocyte recruitment.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AGER
  - MOK
  - SLC2A1
  - SOD1
  - SOD2
  - SOD3
  - NOS3
  - ENO4
  - DECR1
  - PARP1
  - COL11A2
  - PARP2
  - PARP3
  - PARP4
  - PARP6
  - PARP8
  - PARP9
  - PARP10
  - PARP11
  - PARP12
  - PARP14
  - PARP15
  - PARP16
  - TNKS
  - TNKS2
  - TIPARP
  - GAPDH
  - GAPDHP44
  - TNF
  - ICAM1
  - ICAM2
  - ICAM3
  - ICAM4
  - ICAM5
  - IL16
  - SELE
  - SELL
  - SELP
  - CXCL10
  - CXCL11
  - CXCL12
  - CXCL13
  - CXCL14
  - CXCL9
  - PF4
  - CXCL1
  - CXCL2
  - CXCL3
  - CXCL5
  - CXCL6
  - CXCL8
  - PPBP
  - IL6
  - CCL2
  - parp14rs2.1
  - gapdh
  - gapdhs
  - tnfa
  - tnfb
  - il16
  - il6
---
